Saturday, September 29, 2007

Stem cell from bone marrow may hold hope for multiple sclerosis patients
ANI via Yahoo! India News Fri, 28 Sep 2007 3:38 AM PDT
London, September 28 (ANI): Medical practitioners at the Frenchay hospital, near Bristol, are conducting clinical trials with stem cells drawn from patients' own bone marrow to see whether they can travel to damaged parts of the brain and repair them. Tens of thousands of patients with multiple sclerosis (MS) may benefit from the treatment if the tests become successful, say the ...

Study of bone marrow stem cells in multiple sclerosis
News-Medical-Net Thu, 27 Sep 2007 6:12 PM PDT
A new pilot clinical trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis has started at Frenchay Hospital.

Hope for multiple sclerosis patients
The Times of India Fri, 28 Sep 2007 8:12 AM PDT
LONDON: Medical practitioners at the Frenchay hospital, near Bristol, are conducting clinical trials with stem cells drawn from patients' own bone marrow to see whether they can travel to damaged parts of the brain and repair them.

Stem cell injection trial 'raises hope of MS cure'
Daily Mail Fri, 28 Sep 2007 2:39 AM PDT
A pioneering new treatment which could help thousands of multiple sclerosis suffers "recover" from the incurable disease is being trialled for the first time at a British hospital

Health BRIEFS
McKinney Courier-Gazette Fri, 28 Sep 2007 0:08 AM PDT
The Multiple Sclerosis Support Group will meet at 7 p.m. Monday at the Medical Center of McKinney Wysong Campus, 130 S. Central Expressway, in Classroom 1.

MS treatment Tysabri wins approval in New Zealand
Reuters - USA
I: Quote, Profile, Research) said their drug Tysabri has been approved in New Zealand for treatment of the relapsing remitting form of multiple sclerosis. ...
See all stories on this topic

Risk-Averse Behavior Entrenched at FDA
Genetic Engineering News (press release) - New Rochelle,NY,USA
... warnings on the labels of antidepressants and the discovery of previously unknown adverse reactions to NSAIDs and the multiple sclerosis drug Tysabri. ...
See all stories on this topic

Opexa Says Its Safety Board Recommends For Continuation Of Phase ...
RTT News - Williamsville,NY,USA
... Texas - based Opexa Therapeutics, Inc. (OPXA) said its Data Safety Monitoring Board has not recorded any safety issues with Phase IIb study of Tovaxin ...
See all stories on this topic

Hope for multiple sclerosis patients
Times of India - India
LONDON: Medical practitioners at the Frenchay hospital, near Bristol, are conducting clinical trials with stem cells drawn from patients' own bone marrow to ...
See all stories on this topic

Oprah Winfrey Talks To Michael Moore About Sicko And Health Care ...
Best Syndication - Pinon Hills,CA,USA
A comment came from a former hospital CEO, William Blaine of Minnesota, who said "I retired early because I had Multiple Sclerosis (MS) and could no longer ...
See all stories on this topic

News in Brief
Times Online - UK
A pioneering new treatment that could help thousands of multiple sclerosis sufferers to "recover" from the incurable disease is being tested for the first ...
See all stories on this topic

A TREATMENT which could halt the effects of multiple sclerosis is ...
Glasgow Daily Record - Glasgow,Scotland,UK
Patients are being injected with bone marrow stem cells, which it's hoped will repair damaged areas of the brain and spinal cord and "reverse" their ...
See all stories on this topic

0 Comments:

Post a Comment

<< Home